Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-03 12:10 pm Purchase | 2022-12-31 | 13G | Cullinan Oncology, Inc. CGEM | BlackRock Inc. BLK | 2,506,215 5.500% | 2,506,215 (New Position) | Filing History |
| 2022-02-14 1:23 pm Purchase | 2021-12-31 | 13G | Cullinan Oncology, Inc. CGEM | BIOTECHNOLOGY VALUE FUND L P | 5,369,459 12.300% | 975,000 (+22.19%) | Filing History |
| 2022-02-11 3:05 pm Sale | 2021-12-31 | 13G | Cullinan Oncology, Inc. CGEM | Foresite Capital Fund V L.P. | 1,524,008 3.500% | -2,117,871 (-58.15%) | Filing History |
| 2022-02-11 1:39 pm Purchase | 2021-12-31 | 13G | Cullinan Oncology, Inc. CGEM | CHI Advisors LLC | 2,476,720 5.670% | 2,476,720 (New Position) | Filing History |
| 2022-02-10 4:49 pm Purchase | 2021-12-31 | 13G | Cullinan Oncology, Inc. CGEM | Jovan-Embiricos Morana | 6,279,713 14.300% | 6,279,713 (New Position) | Filing History |
| 2022-02-09 3:43 pm Purchase | 2021-12-31 | 13G | Cullinan Oncology, Inc. CGEM | VANGUARD GROUP INC | 2,366,808 5.420% | 2,366,808 (New Position) | Filing History |
| 2021-12-20 4:52 pm Purchase | 2021-12-16 | 13G | Cullinan Oncology, Inc. CGEM | BIOTECHNOLOGY VALUE FUND L P | 4,394,459 10.100% | 1,787,653 (+68.58%) | Filing History |
| 2021-11-08 5:20 pm Purchase | 2021-10-28 | 13G | Cullinan Oncology, Inc. CGEM | BIOTECHNOLOGY VALUE FUND L P | 2,606,806 6.000% | 2,606,806 (New Position) | Filing History |
| 2021-01-19 4:33 pm Purchase | 2021-01-12 | 13D | Cullinan Oncology, Inc. CGEM | UBS Oncology Impact Fund L.P. | 8,546,093 19.600% | 8,546,093 (New Position) | Filing History |
| 2021-01-15 06:05 am Purchase | 2021-01-08 | 13G | Cullinan Oncology, Inc. CGEM | Foresite Capital Fund V L.P. | 3,641,879 8.800% | 3,641,879 (New Position) | Filing History |